These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26711695)

  • 1. Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.
    Tsujino K; Sheppard D
    Curr Rheumatol Rep; 2016 Jan; 18(1):4. PubMed ID: 26711695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of scleroderma: current state and recent development.
    Asano Y; Sato S
    Curr Rheumatol Rep; 2013 Dec; 15(12):382. PubMed ID: 24150871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Models of Skin Fibrosis.
    Rius Rigau A; Luber M; Distler JHW
    Methods Mol Biol; 2021; 2299():371-383. PubMed ID: 34028755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in animal models of systemic sclerosis.
    Asano Y
    J Dermatol; 2016 Jan; 43(1):19-28. PubMed ID: 26782003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of scleroderma: lessons from transgenic and knockout mice.
    Derrett-Smith EC; Denton CP; Sonnylal S
    Curr Opin Rheumatol; 2009 Nov; 21(6):630-5. PubMed ID: 19730378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights on chemically induced animal models of systemic sclerosis.
    Batteux F; Kavian N; Servettaz A
    Curr Opin Rheumatol; 2011 Nov; 23(6):511-8. PubMed ID: 21857225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of scleroderma: recent progress.
    Marangoni RG; Varga J; Tourtellotte WG
    Curr Opin Rheumatol; 2016 Nov; 28(6):561-70. PubMed ID: 27533324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In perspective: murine models of scleroderma.
    Wu M; Varga J
    Curr Rheumatol Rep; 2008 Jul; 10(3):173-82. PubMed ID: 18638424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
    Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
    Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of scleroderma.
    Lakos G; Takagawa S; Varga J
    Methods Mol Med; 2004; 102():377-93. PubMed ID: 15286396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
    Asano Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models in systemic sclerosis.
    Rogai V; Lories RJ; Guiducci S; Luyten FP; Matucci Cerinic M
    Clin Exp Rheumatol; 2008; 26(5):941-6. PubMed ID: 19032835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyopathy in murine models of systemic sclerosis.
    Venalis P; Kumánovics G; Schulze-Koops H; Distler A; Dees C; Zerr P; Palumbo-Zerr K; Czirják L; Mackevic Z; Lundberg IE; Distler O; Schett G; Distler JH
    Arthritis Rheumatol; 2015 Feb; 67(2):508-16. PubMed ID: 25371068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
    Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
    J Immunol; 2016 Oct; 197(8):3018-3028. PubMed ID: 27613696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis.
    Asano Y
    Int J Biochem Cell Biol; 2015 Oct; 67():86-91. PubMed ID: 26055516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis: a prototypic multisystem fibrotic disorder.
    Varga J; Abraham D
    J Clin Invest; 2007 Mar; 117(3):557-67. PubMed ID: 17332883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Mouse Model of Bleomycin-Induced Skin Fibrosis.
    Błyszczuk P; Kozlova A; Guo Z; Kania G; Distler O
    Curr Protoc Immunol; 2019 Sep; 126(1):e88. PubMed ID: 31483105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
    Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal Injections of Bleomycin to Model Skin Fibrosis.
    Yamamoto T
    Methods Mol Biol; 2017; 1627():43-47. PubMed ID: 28836193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of scleroderma: fresh insights.
    Artlett CM
    Curr Opin Rheumatol; 2010 Nov; 22(6):677-82. PubMed ID: 20720495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.